Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections

Clicks: 240
ID: 274627
2004
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Despite the presence of multiple predictors of increased mortality, high-dose GTX therapy in these high-risk patients with cancer was associated with better than expected survival rates.
Reference Key
a2004cancerimpact Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Safdar A;Hanna HA;Boktour M;Kontoyiannis DP;Hachem R;Lichtiger B;Freireich EJ;Raad II;;
Journal cancer
Year 2004
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/15529309
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine adult female male aged middle aged Retrospective Studies Evaluation Study case-control studies neoplasms / complications* leukemia / complications neutropenia / complications fungemia / mortality neoplasms / mortality amar safdar issam i raad granulocytes / transplantation* pmid:15529309 doi:10.1002/cncr.20710 hend a hanna candidiasis / mortality candidiasis / therapy* fungemia / therapy* leukemia / mortality leukocyte transfusion* / adverse effects

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.